BR0110129A - Composição farmacêutica - Google Patents

Composição farmacêutica

Info

Publication number
BR0110129A
BR0110129A BR0110129-3A BR0110129A BR0110129A BR 0110129 A BR0110129 A BR 0110129A BR 0110129 A BR0110129 A BR 0110129A BR 0110129 A BR0110129 A BR 0110129A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
release phase
paracetamol
unique
pharmacokinetic properties
Prior art date
Application number
BR0110129-3A
Other languages
English (en)
Inventor
Yue Shing Chan
Timothy James Grattan
Bounkhiene Sengmanee
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9890126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0110129(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR0110129A publication Critical patent/BR0110129A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Confectionery (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA". Uma composição farmacêutica compreendendo uma fase de liberação imediata e uma fase de liberação prolongada de paracetamol é descrita que tem um perfil de dissolução in vitro singular resultando em propriedades farmacocinéticas vantajosas.
BR0110129-3A 2000-04-19 2001-04-12 Composição farmacêutica BR0110129A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0009522.4A GB0009522D0 (en) 2000-04-19 2000-04-19 Composition
PCT/EP2001/004302 WO2001080834A1 (en) 2000-04-19 2001-04-12 Composition

Publications (1)

Publication Number Publication Date
BR0110129A true BR0110129A (pt) 2002-12-31

Family

ID=9890126

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110129-3A BR0110129A (pt) 2000-04-19 2001-04-12 Composição farmacêutica

Country Status (24)

Country Link
US (2) US7943170B2 (pt)
EP (1) EP1274402B1 (pt)
JP (1) JP2003531165A (pt)
KR (1) KR100845660B1 (pt)
CN (1) CN100335046C (pt)
AT (1) ATE438388T1 (pt)
AU (2) AU6021201A (pt)
BR (1) BR0110129A (pt)
CA (1) CA2406373C (pt)
CO (1) CO5280073A1 (pt)
CY (1) CY1109483T1 (pt)
CZ (1) CZ303275B6 (pt)
DE (1) DE60139462D1 (pt)
DK (1) DK1274402T3 (pt)
EA (1) EA006103B1 (pt)
ES (1) ES2329971T3 (pt)
GB (1) GB0009522D0 (pt)
HU (1) HU230033B1 (pt)
MX (1) MXPA02010347A (pt)
NZ (1) NZ521799A (pt)
TW (1) TWI282286B (pt)
UA (1) UA76417C2 (pt)
WO (1) WO2001080834A1 (pt)
ZA (1) ZA200208084B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
CN100348974C (zh) * 2003-09-30 2007-11-14 北京东方凯恩医药科技有限公司 一种药物组合物的检测方法
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
CN101252932B (zh) 2005-09-09 2012-10-03 安吉利尼莱博法姆有限责任公司 用于一天给药一次的曲唑酮组合物
DK1940467T3 (da) 2005-09-09 2017-02-13 Paladin Labs Inc Lægemiddelsammensætning med langvarig frigivelse
US20080057122A1 (en) * 2006-08-31 2008-03-06 Aaipharma Inc. Acetaminophen pharmaceutical compositions
KR20100069685A (ko) * 2007-10-16 2010-06-24 라보팜 인코포레이트 아세트아미노펜과 트라마돌의 지속 방출을 위한 이중층 조성물
US8486448B2 (en) 2007-12-17 2013-07-16 Paladin Labs Inc. Misuse preventative, controlled release formulation
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
US8372432B2 (en) * 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
US8377453B2 (en) * 2008-03-11 2013-02-19 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
AU2009327312A1 (en) 2008-12-16 2011-08-04 Labopharm Europe Limited Misuse preventative, controlled release formulation
US8524278B2 (en) * 2009-02-13 2013-09-03 Romark Laboratories L.C. Controlled release pharmaceutical formulations of nitazoxanide
US20110052685A1 (en) * 2009-08-31 2011-03-03 Depomed, Inc. Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US20140065213A1 (en) * 2011-05-06 2014-03-06 GlaxoSmithKline, LLC Sustained Release Paracetamol Formulations
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US9050335B1 (en) 2011-05-17 2015-06-09 Mallinckrodt Llc Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US20140206740A1 (en) * 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
EA032913B1 (ru) * 2012-10-18 2019-08-30 Эббви Инк. Препараты производных пиримидиндиона
WO2016042570A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release formulation of acetaminophen
ES2884973T3 (es) 2016-03-09 2021-12-13 Nls Pharmaceutics Ag Comprimido multicapa de mazindol de IR/SR y su utilización para el tratamiento del trastorno por déficit de atención/hiperactividad (ADHD)
BR112020021812A2 (pt) * 2018-04-25 2021-02-23 Neurocentria, Inc. forma de dosagem, método para tratar uma doença, distúrbio, síndrome e/ou afecção em um paciente com necessidade do mesmo, e método para produzir uma forma de dosagem
CN121570438A (zh) * 2026-01-29 2026-02-27 海南亚洲制药股份有限公司 一种复方氨酚烷胺胶囊的缓控释制剂工艺及配方

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058562B (en) * 1979-09-14 1983-11-30 Beecham Group Ltd Pharmaceutical compositions containing paracetamol and ascorbic acid
US4786503A (en) 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
EP0418596A3 (en) 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
US5900425A (en) 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
US5773031A (en) 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
BE1011045A3 (fr) 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
FR2766708B1 (fr) 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
US5945123A (en) 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
US6254891B1 (en) 1998-09-03 2001-07-03 Ascent Pediatrics, Inc. Extended release acetaminophen
US6126967A (en) * 1998-09-03 2000-10-03 Ascent Pediatrics Extended release acetaminophen particles
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
US7897172B2 (en) 2004-05-18 2011-03-01 L. Perrigo Company Tablets exhibiting reduced drug release variability

Also Published As

Publication number Publication date
MXPA02010347A (es) 2003-04-25
CA2406373A1 (en) 2001-11-01
DE60139462D1 (de) 2009-09-17
EP1274402B1 (en) 2009-08-05
US20110177168A1 (en) 2011-07-21
HU230033B1 (hu) 2015-05-28
TWI282286B (en) 2007-06-11
US7943170B2 (en) 2011-05-17
UA76417C2 (en) 2006-08-15
ES2329971T3 (es) 2009-12-03
HUP0300698A2 (hu) 2003-07-28
CZ20023470A3 (cs) 2003-03-12
DK1274402T3 (da) 2009-11-16
KR100845660B1 (ko) 2008-07-10
HUP0300698A3 (en) 2004-09-28
AU2001260212B2 (en) 2006-09-21
CZ303275B6 (cs) 2012-07-11
AU2001260212C1 (en) 2020-07-16
EP1274402A1 (en) 2003-01-15
US20040202716A1 (en) 2004-10-14
KR20030009440A (ko) 2003-01-29
WO2001080834A1 (en) 2001-11-01
JP2003531165A (ja) 2003-10-21
ZA200208084B (en) 2003-10-08
CO5280073A1 (es) 2003-05-30
AU6021201A (en) 2001-11-07
EA200200954A1 (ru) 2003-04-24
GB0009522D0 (en) 2000-06-07
PL358123A1 (en) 2004-08-09
NZ521799A (en) 2004-12-24
CN1426298A (zh) 2003-06-25
CN100335046C (zh) 2007-09-05
CY1109483T1 (el) 2014-08-13
ATE438388T1 (de) 2009-08-15
CA2406373C (en) 2010-06-29
EA006103B1 (ru) 2005-08-25
HK1053601A1 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
BR0110129A (pt) Composição farmacêutica
CY2009015I2 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
GB2365772A (en) Factor
ES2187201T3 (es) Empleo de esteroles y de esterolesteres a nanoescala.
TWI235068B (en) Sustained-release pharmaceutical composition
BR0112054A (pt) Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico
CY1108918T1 (el) Φαρμακευτικοι συνδυασμοι οξυκωδονης και ναλοξονης
DE60143393D1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
BR9915285A (pt) Composição farmacêutica para liberação modificada de um sensitivador de insulina e um outro agente antidiabético
BR9711194A (pt) Uso de agente quelante clioquinol para a fabricação de uma composição farmacêutica para o tratamento de doença de alzheimer.
BR0313428A (pt) Composições farmacêuticas de drogas semi-ordenados e polìmeros
BR0209283A (pt) Método para a fabricação de uma composição farmacêutica de baixa dosagem tendo distribuição e potência de droga uniforme
HUP0302635A3 (en) Phospholipid derivatives of valproic acid and mixtures thereof
BR9809571A (pt) Composição medicinal e processo para produzì-la
WO2002011694A3 (en) Compositions and dosage forms for application in the oral cavity in the treatment of mykoses
BR9915215A (pt) Composição farmacêutica para liberação modificada de sensibilizador de insulina
BR0113165A (pt) Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados
ITMI20010957A0 (it) Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
PL360289A1 (en) Arylpiperazine derivatives and their use as psychotropic agents
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
EE200900049A (et) Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina
BR9810996A (pt) Composição farmacêutica
DE50015195D1 (de) Feste paroxetin enthaltende zubereitungen
BR0001144B1 (pt) Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
DE60121142D1 (de) Zusammensetzung die paracetamol und niflumic säure enthält

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 24 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25B Requested transfer of rights rejected

Owner name: SMITHKLINE BEECHAM P.L.C. (GB)

B25E Requested change of name of applicant rejected

Owner name: SMITHKLINE BEECHAM P.L.C. (GB)

B25B Requested transfer of rights rejected

Owner name: SMITHKLINE BEECHAM P.L.C. (GB)

B25E Requested change of name of applicant rejected

Owner name: SMITHKLINE BEECHAM P.L.C. (GB)